Evan L. Reynolds

1.4k total citations
53 papers, 952 citations indexed

About

Evan L. Reynolds is a scholar working on Neurology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Evan L. Reynolds has authored 53 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 18 papers in Physiology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Evan L. Reynolds's work include Pain Mechanisms and Treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Evan L. Reynolds is often cited by papers focused on Pain Mechanisms and Treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Evan L. Reynolds collaborates with scholars based in United States, Denmark and Australia. Evan L. Reynolds's co-authors include Mousumi Banerjee, Brian C. Callaghan, Eva L. Feldman, Rodica Pop‐Busui, Charles Burant, Amy E. Rothberg, Marco Agostoni, Benjamin J. Koestler, Christopher M. Waters and Jonathan P. Massie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Diabetes Care.

In The Last Decade

Evan L. Reynolds

47 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan L. Reynolds United States 16 385 274 182 127 82 53 952
Zohaib Iqbal United Kingdom 13 326 0.8× 196 0.7× 87 0.5× 183 1.4× 163 2.0× 29 858
Lorenzo Romano Italy 19 323 0.8× 89 0.3× 172 0.9× 67 0.5× 110 1.3× 37 967
Hiroki Fujii Japan 21 286 0.7× 81 0.3× 108 0.6× 325 2.6× 97 1.2× 56 1.2k
Jie Guo China 19 210 0.5× 67 0.2× 360 2.0× 76 0.6× 92 1.1× 135 1.3k
Elizabeth J. Simpson United Kingdom 20 571 1.5× 98 0.4× 227 1.2× 165 1.3× 106 1.3× 58 1.3k
Suman Kushwaha India 19 259 0.7× 166 0.6× 238 1.3× 36 0.3× 108 1.3× 84 1.0k
Caterina Maria Gambino Italy 25 372 1.0× 263 1.0× 342 1.9× 47 0.4× 163 2.0× 82 2.0k
Astrid Steinbrecher Germany 21 260 0.7× 63 0.2× 250 1.4× 129 1.0× 52 0.6× 40 1.0k
Sirkka Goebeler Finland 19 308 0.8× 54 0.2× 224 1.2× 68 0.5× 158 1.9× 42 1.1k
Xiufang Lin China 19 350 0.9× 45 0.2× 326 1.8× 74 0.6× 129 1.6× 42 1.2k

Countries citing papers authored by Evan L. Reynolds

Since Specialization
Citations

This map shows the geographic impact of Evan L. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan L. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan L. Reynolds more than expected).

Fields of papers citing papers by Evan L. Reynolds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan L. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan L. Reynolds. The network helps show where Evan L. Reynolds may publish in the future.

Co-authorship network of co-authors of Evan L. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Evan L. Reynolds. A scholar is included among the top collaborators of Evan L. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan L. Reynolds. Evan L. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reynolds, Evan L., et al.. (2025). Racial and Ethnic Differences in Peripheral Neuropathy Risk Factors Among United States Adults. Neurology. 105(3). e213851–e213851.
2.
Lin, Chun Chieh, et al.. (2025). Cost Trends of New-To-Market Neurologic Medications. Neurology. 104(6). e213428–e213428. 2 indexed citations
3.
Callaghan, Brian C., Evan L. Reynolds, Melissa A. Elafros, et al.. (2025). Diagnostic Testing for Patients With Peripheral Neuropathy. JAMA Neurology. 82(4). 420–420.
4.
Callaghan, Brian C., Evan L. Reynolds, A. Gordon Smith, et al.. (2025). The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type. Annals of Clinical and Translational Neurology. 12(7). 1408–1417. 2 indexed citations
5.
Holmes, Crystal, et al.. (2025). Cognitive impairment is associated with poor diabetic foot ulcer outcomes. Primary care diabetes. 19(5). 527–532.
6.
Lin, Chun Chieh, et al.. (2025). Wait Time to See a Neurologist After Referral Among Medicare Participants. Neurology. 104(3). e210217–e210217. 3 indexed citations
7.
Callaghan, Brian C., RanjitMohan Anjana, Evan L. Reynolds, et al.. (2025). Severe insulin‐deficient diabetes is at the opposite end of the neuropathy spectrum to mild aged‐related diabetes. Journal of Diabetes Investigation. 16(6). 1045–1049. 1 indexed citations
8.
Stino, Amro, Evan L. Reynolds, Maya Watanabe, & Brian C. Callaghan. (2024). Intravenous immunoglobulin and plasma exchange prescribing patterns for Guillain‐Barre Syndrome in the United States—2001 to 2018. Muscle & Nerve. 70(6). 1192–1199. 1 indexed citations
9.
Watanabe, Maya, Evan L. Reynolds, Mousumi Banerjee, et al.. (2024). Bidirectional Associations Between Mental Health Disorders and Chronic Diabetic Complications in Individuals With Type 1 or Type 2 Diabetes. Diabetes Care. 47(9). 1638–1646. 3 indexed citations
10.
Lin, Chun Chieh, et al.. (2024). Costs Are Still on the Rise for Commonly Prescribed Branded Neurologic Medications. Neurology. 103(10). e210029–e210029. 3 indexed citations
11.
Reynolds, Evan L., Kristen Votruba, M. Watanabe, et al.. (2023). The Effect of Surgical Weight Loss on Cognition in Individuals with Class II/III Obesity. The journal of nutrition health & aging. 27(12). 1153–1161. 2 indexed citations
12.
Reynolds, Evan L., Brian C. Callaghan, Michael Gaies, & Mousumi Banerjee. (2023). Regression Trees and Ensemble for Multivariate Outcomes. Sankhya B. 85(1). 77–109. 1 indexed citations
13.
Watanabe, Maya, et al.. (2022). Diagnostic characteristics of nerve conduction study parameters for vasculitic neuropathy. Muscle & Nerve. 67(1). 45–51. 8 indexed citations
14.
Reynolds, Evan L., Gülçin Akıncı, Mousumi Banerjee, et al.. (2021). The determinants of complication trajectories in American Indians with type 2 diabetes. JCI Insight. 6(10). 6 indexed citations
15.
Reynolds, Evan L., et al.. (2021). Executive Functioning in Extreme Obesity: Contributions from Metabolic Status, Medical Comorbidities, and Psychiatric Factors. Obesity Surgery. 31(6). 2669–2681. 3 indexed citations
16.
Poznak, Catherine Van, Evan L. Reynolds, Cherry L. Estilo, et al.. (2020). Osteonecrosis of the jaw risk factors in bisphosphonate‐treated patients with metastatic cancer. Oral Diseases. 28(1). 193–201. 7 indexed citations
17.
Callaghan, Brian C., et al.. (2020). Central Obesity is Associated With Neuropathy in the Severely Obese. Mayo Clinic Proceedings. 95(7). 1342–1353. 63 indexed citations
18.
Reynolds, Evan L., Brian C. Callaghan, Mousumi Banerjee, Eva L. Feldman, & Vijay Viswanathan. (2020). The metabolic drivers of neuropathy in India. Journal of Diabetes and its Complications. 34(10). 107653–107653. 11 indexed citations
19.
Callaghan, Brian C., Evan L. Reynolds, Mousumi Banerjee, et al.. (2018). Longitudinal pattern of pain medication utilization in peripheral neuropathy patients. Pain. 160(3). 592–599. 20 indexed citations
20.
Callaghan, Brian C., Rong Xia, Evan L. Reynolds, et al.. (2018). Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists. Clinical Neurophysiology. 129(3). 654–662. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026